Been holding a substantial amount of shares since the last dilution. I believe in this electroporation technology and like any startup biotech company, clearly understand time is needed to prove successful. Not planning to do anything until it does.
Great to see positive FEYE exposure on CNBC going into earnings. The fact high-tech hackers continue to make the news exposing security breaches in major companies along with, of all places - the White House, will no doubt keep sales people very busy in FEYE.
I expect a nice surprise come earnings. And the talk amongst analysts leading up to 4/30 earnings release will push the pps to the resistance $45 level. Any surprise results will catapult this stock through this resistance level and come mid-May we'll see this above $50. IMO of course but no doubt achievable.
Sentiment: Strong Buy
Usually right?? That's a joke. See how he did on AVNR last year. AVNR finished #1 on the IBB 2014 list. He was forced to eat crow and admit he was wrong after years of negative comments regarding AVNR.
Baker Bros timing was impeccable with AVNR. I was long - real long lol w/ AVNR and reaped the rewards of the buyout. Would like to see the same thing happen here. Good luck to you.
Sounds like your timing with AVNR was impeccable also..lol. Good for you. You didn't have to endure the years orchestrated bear raids, the famous flash crash, the erroneous Gravity Research report, the countless negative articles by Seeking Alpha, and lastly, The Street's Adam Feuernstein constant bashing.
The biotech industry is arguably the most volatile sector because of the research and expense that goes into getting a drug from inception to the market. One FDA approval or denial can make or break a biotech company. So it is a favorite target of big short hedge funds because of this volatility and the capability to control the pps with timely negative articles during the testing phases. AVNR was a perfect example up until Phase 2 AVP-923 results were released for treating Alzheimer agitation. This was their dam opener for the potential of this drug and the Alzheimer exposure it received seriously put AVNR on the map. Institutions piled on, Baker Bros increased their holdings, and AVNR was bought out in a matter of months - allowing many longs to finally break out that victory cigar.
With all this said, I expect volatility to increase with CYTR also as we approach major catalyst news. It has quite the short presence also and I would expect nothing less than increased efforts on their part to keep the pps suppressed. Nevertheless, I'm counting on CYTR to have a happy ending - a dam opener also like AVNR and will be holding until it does. GL!
There has been notable accumulation going on the last few weeks with CYTR. I actually added to my position this morning. Momentum is with the longs.
Thanks Sarge - I'm a day late but nevertheless, good reading - and listening - material with my Sunday morning coffee.... I've been away a bit and missed the opportunity to add last week when SPPI dropped to the $5.60's...
I've got a chunk of change in this biotech stock and willing to add to it if it dips again. Did add to my CYTR holding the end of March. I like the momentum that company is heading and see a lot of similarities with CYTR to AVNR. May it have the same ending..lol
Well folks, if you believe in the technology you will hold and/or add like I will be. It doesn't take a Sherlock to realize Biotech companies need time - A LOT of time - and money to get their products from startup to market. Choices are to either trade a company or invest in a company and the stock market has given the opportunity for investors to choose which side of the fence they want to be on.
Because of the volatility of most start up biotech companies, FDA approvals can make or break a biotech company for risk/rewards are the biggest amongst any sector and ONCS is no exception. I'm not surprised the pps drifted down to the levels of the last round of dilution. It certainly looks like another round of dilution will be taking place this year. I am ok with that and will be adding to my position when that happens.
I had a close friend die from metastatic melanoma a couple of years ago and decided to research companies working on advanced treatment of this death-sentence disease. I bought into ONCS during the last round of dilution. I believe in this electroporation technology and believe ONCS will succeed and find enormous value in utilizing this product to fight cancerous tumors.
Good luck to all longs moving forward! I'm in this for the long haul.
I'll play the role... I doubled up on my position this morning. Clearly there's accumulation going on.
No doubt pps is recoiling here at 4 bucks. It is very apparent accumulation is going on. With the low volume of late, Hedge Funds could easily step this down with their incremental 100-share trades which they have done on several occasions only to level back off at 4 bucks. I definitely see a strong move up soon but the pps may take one last hit as new limit orders get taken out prior to the move up. When I see that, I'm adding to my 80K shares.
Sentiment: Strong Buy